Last reviewed · How we verify

NCT06129708

Effect of Aquatic Exercise Versus Aerobic Exercise on Primary Dysmenorrhea and Quality of Life in Adolescent Females

Completed NA Last updated 13 November 2023
What this trial tests

NA trial testing Aquatic Exercise in Dysmenorrhea Primary in 60 participants. Completed in 1 October 2023.

Timeline
1 October 2022
Primary endpoint
1 October 2023
1 October 2023

Quick facts

Lead sponsorCairo University
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposetreatment
Enrollment60
Start date1 October 2022
Primary completion1 October 2023
Estimated completion1 October 2023
Sites1 location across Egypt

Drugs / interventions tested

Conditions studied

Sponsor

Cairo University

Who can join

Adults 14 to 20, female only, with Dysmenorrhea Primary. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study was conducted to determine the difference between impact of aerobic and aquatic exercise on primary dysmenorrhea and quality of life in adolescent girls.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Effect of aquatic exercise versus aerobic exercise on primary dysmenorrhea and quality of life in adolescent females: A randomized controlled trial.
    Abdelrahman AY, El-Kosery SM, Abbassy AH, Botla AM. · · 2024 · cited 4× · PMID 38767193 · DOI 10.1002/pri.2095

Verify or expand the search:

Other trials of Aquatic Exercise

Trials testing the same drug.

Other recruiting trials for Dysmenorrhea Primary

Currently open trials in the same condition.

Other Cairo University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06129708.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing